Alector, Inc. Lease, Cost
Alector, Inc. (ALEC) reported Lease, Cost of $8.99 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2026-02-25
- Alector, Inc. lease, cost for the quarter ending 2019-12-31 was $1.23M.
- Alector, Inc. lease, cost for the quarter ending 2019-09-30 was $1.23M.
- Alector, Inc. lease, cost for the quarter ending 2019-06-30 was $1.64M.
- Alector, Inc. lease, cost for the quarter ending 2019-03-31 was $1.90M.
- Alector, Inc. lease, cost for fiscal 2025 was $8.99M, a 20.52% increase from fiscal 2024.
- Alector, Inc. lease, cost for fiscal 2024 was $7.46M, a 2.29% increase from fiscal 2023.
- Alector, Inc. lease, cost for fiscal 2023 was $7.29M, a 3.42% decline from fiscal 2022.
- Alector, Inc. lease, cost for fiscal 2022 was $7.55M, a 6.22% increase from fiscal 2021.
| Period end | Lease, Cost 3 month | Lease, Cost 6 month | Lease, Cost 9 month | Lease, Cost 12 month |
|---|---|---|---|---|
| 2025-12-31 | $8.99M 10-K · filed 2026-02-25 | |||
| 2024-12-31 | $7.46M 10-K · filed 2026-02-25 | |||
| 2023-12-31 | $7.29M 10-K · filed 2025-02-26 | |||
| 2022-12-31 | $7.55M 10-K · filed 2025-02-26 | |||
| 2021-12-31 | $7.11M 10-K · filed 2024-02-27 | |||
| 2020-12-31 | $5.56M 10-K · filed 2023-02-28 | |||
| 2019-12-31 | $1.23M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $2.46M derived: sum of 2 quarters · filed 2022-02-24 | $4.11M derived: sum of 3 quarters · filed 2022-02-24 | $6.01M 10-K · filed 2022-02-24 |
| 2019-09-30 | $1.23M 10-Q · filed 2019-11-12 | $2.87M derived: sum of 2 quarters · filed 2019-11-12 | $4.78M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $1.64M 10-Q · filed 2019-08-12 | $3.55M 10-Q · filed 2019-08-12 | ||
| 2019-03-31 | $1.90M 10-Q · filed 2019-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |